The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Many roads lead to oncogene-induced senescence
Abstract
Oncogene-induced senescence is a mechanism of tumor suppression that restricts the progression of benign tumors. Important advances have been made toward elucidating the mechanisms that regulate this response; however, there is presently no unified model that integrates all current findings. DNA damage, replicative stress, reactive oxygen species, heterochromatin formation and negative feedback signaling networks have all been proposed to play an integral role in promoting senescence in response to various oncogenic insults. In all cases, these signals have been shown to function through Rb and p53, but utilize different intermediaries. Thus, it appears that senescence is not triggered by a single, linear series of events, but instead is regulated by a complex signaling network. Accordingly, multiple proteins may cooperate to establish a senescence response, but the limiting signal(s) may be dictated by the initiating genetic alteration and/or tissue type. This review will focus on integrating current models and will highlight data that provide new insight into the signals that function to suppress human tumor development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene-induced senescence (OIS), characterized by aberrant DNA replication and the associated DNA damage response, is affected by activated oncogenes or the loss of tumor-suppressor genes in healthy cells”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [61]
In the citing paper
“The activation of only one or both pathways for the execution and maintenance of the senescence program is dictated by the type of stress signal, the tissue, and the species of origin [67], or by a compensatory response to signaling imbalances.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [67]
In the citing paper
“A hallmark of senescence is its stable cell cycle arrest coordinated by interplay between the RB and p53 tumor suppressor networks (Courtois-Cox et al., 2008).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Courtois-Cox et al., 2008
In the citing paper
“In addition to the RB pathway, the p53 tumor suppressor also contributes to senescence (Courtois-Cox et al., 2008).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Courtois-Cox et al., 2008
In the citing paper
“strong evidence places RB–E2F activity and associated chromatin-regulating complexes, such as SUV39H1, as a key regulators of senescence in cells in culture121–124.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [123]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 3×
“The earliest in vitro studies demonstrated that oncogeneinduced senescence could be bypassed by inactivating Rb and p53 (Serrano et al., 1997).”
BackgroundResultInfluentialTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“However, even at this time, additional cooperating genetic alterations were known to be required for Ras to transform primary cells (Land et al., 1983).”
BackgroundHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“However, several studies have now established a more causal role for senescence in this process (Sarkisian et al., 2007; Ventura et al., 2007; Xue et al., 2007).”
BackgroundResultRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“SAHFs accumulate during oncogene-induced senescence through a multi-step process and are thought to suppress stably the expression of E2F target genes via the recruitment of Rb and heterochromatin proteins (Narita et al., 2003; Adams et al., 2007).”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“However, several reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 5×
“…reports have now demonstrated that oncogene-induced senescence does indeed occur in vivo in human tumors and in mouse tumor models (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007; Sarkisian et al., 2007).”
BackgroundResultInfluentialOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 2×
“Moreover, it appears that at least a subset of oncogenes can only trigger senescence if cells are allowed to enter S phase (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 3×
“Consistent with this model, Di Micco et al. (2006) have shown that senescent cells stall in S phase, have an augmented number of active replicons and exhibit defects in DNA replication fork progression, resulting in an activation of ATR and ultimately ATM.”
BackgroundRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 2×
“However, several studies have now established a more causal role for senescence in this process (Sarkisian et al., 2007; Ventura et al., 2007; Xue et al., 2007).”
BackgroundResult
Cited by
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“This biological clock, known as the “Hayflick limit,” is caused by a progressive shortening of telomeres upon each cell division and represents a physiological response to prevent genomic instability and therefore accumulation of DNA damage (79, 150).”
BackgroundInfluentialFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
“Likewise, p53 is required for the growth arrest (Campisi and d’Adda di Fagagna, 2007; Courtois-Cox et al, 2008), but not the SASP; in fact, cells lacking functional p53 secrete markedly higher levels of most SASP factors.”
Background
Metadata
- Authors
- Courtois-Cox, S., Jones, S. L., & Cichowski, K.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Cichowski, K
- ORCID
- Cichowski, K
- Venue
- Oncogene
- Published
- 2008-01-14
- Volume
- 27
- Issue
- 20
- Pages
- 2801-2809
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2001353514
- Cited by
- 397
- References
- 57
- Citations by year
- 2026: 8 · 2025: 28 · 2024: 17 · 2023: 23 · 2022: 24 · 2021: 21 · 2020: 22 · 2019: 26 · 2018: 22 · 2017: 23 · 2016: 34 · 2015: 17 · 2014: 19 · 2013: 21 · 2012: 18
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, tumor suppression, DNA damage, replicative stress, reactive oxygen species, heterochromatin formation, Rb, p53
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Oncogenes, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Many roads lead to oncogene-induced senescence. https://app.cochat.ai/papers/10.1038/sj.onc.1210950
- The paper
- Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008). Many roads lead to oncogene-induced senescence. Oncogene. https://doi.org/10.1038/sj.onc.1210950
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.